Cargando…
Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation
Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349848/ https://www.ncbi.nlm.nih.gov/pubmed/30692512 http://dx.doi.org/10.1038/s41419-018-1247-9 |
_version_ | 1783390332500574208 |
---|---|
author | Pooladanda, Venkatesh Thatikonda, Sowjanya Bale, Swarna Pattnaik, Bijay Sigalapalli, Dilep Kumar Bathini, Nagendra Babu Singh, Shashi Bala Godugu, Chandraiah |
author_facet | Pooladanda, Venkatesh Thatikonda, Sowjanya Bale, Swarna Pattnaik, Bijay Sigalapalli, Dilep Kumar Bathini, Nagendra Babu Singh, Shashi Bala Godugu, Chandraiah |
author_sort | Pooladanda, Venkatesh |
collection | PubMed |
description | Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-α) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema. The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS. Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive. Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS. We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression. Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia. Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-κB and HDAC-3. We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-α. Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-α, p38 MAPK, mTOR, and GSK-3β protein expression. Collectively, these results indicate that TNF-α-regulated NF-κB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS. |
format | Online Article Text |
id | pubmed-6349848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63498482019-01-29 Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation Pooladanda, Venkatesh Thatikonda, Sowjanya Bale, Swarna Pattnaik, Bijay Sigalapalli, Dilep Kumar Bathini, Nagendra Babu Singh, Shashi Bala Godugu, Chandraiah Cell Death Dis Article Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-α) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema. The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS. Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive. Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS. We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression. Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia. Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-κB and HDAC-3. We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-α. Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-α, p38 MAPK, mTOR, and GSK-3β protein expression. Collectively, these results indicate that TNF-α-regulated NF-κB and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS. Nature Publishing Group UK 2019-01-28 /pmc/articles/PMC6349848/ /pubmed/30692512 http://dx.doi.org/10.1038/s41419-018-1247-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Pooladanda, Venkatesh Thatikonda, Sowjanya Bale, Swarna Pattnaik, Bijay Sigalapalli, Dilep Kumar Bathini, Nagendra Babu Singh, Shashi Bala Godugu, Chandraiah Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title_full | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title_fullStr | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title_full_unstemmed | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title_short | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
title_sort | nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting tnf-α mediated nf-κb and hdac-3 nuclear translocation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349848/ https://www.ncbi.nlm.nih.gov/pubmed/30692512 http://dx.doi.org/10.1038/s41419-018-1247-9 |
work_keys_str_mv | AT pooladandavenkatesh nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT thatikondasowjanya nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT baleswarna nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT pattnaikbijay nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT sigalapallidilepkumar nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT bathininagendrababu nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT singhshashibala nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation AT goduguchandraiah nimbolideprotectsagainstendotoxininducedacuterespiratorydistresssyndromebyinhibitingtnfamediatednfkbandhdac3nucleartranslocation |